News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,429 Results
Type
Article (14928)
Company Profile (299)
Press Release (267196)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79979)
Career Advice (162)
Deals (13358)
Drug Delivery (39)
Drug Development (50700)
Employer Resources (31)
FDA (5919)
Job Trends (5175)
News (145356)
Policy (10110)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (923)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21802)
ALS (124)
Alzheimer's disease (1030)
Antibody-drug conjugate (ADC) (241)
Approvals (6114)
Artificial intelligence (258)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4568)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (343)
Cancer (3128)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43666)
Collaboration (1148)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1100)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4316)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1380)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31673)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51706)
Executive appointments (621)
FDA (7670)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (981)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (504)
Government (1152)
Grass and pollen (3)
Guidances (166)
Healthcare (6617)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (67)
Infectious disease (1204)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7352)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1412)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (375)
MASH (130)
Medical device (2748)
Medtech (2757)
Mergers & acquisitions (6629)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1949)
Neurotech (1)
NextGen: Class of 2026 (2043)
Non-profit (866)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (327)
Peanut (43)
People (26698)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15473)
Phase 2 (20285)
Phase 3 (12819)
Pipeline (3243)
Policy (90)
Postmarket research (856)
Preclinical (6536)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (647)
Real estate (1449)
Recruiting (12)
Regulatory (9918)
Reports (19)
Research institute (972)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2018)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (4)
Last 7 days (344)
Last 30 days (1281)
Last 365 days (17840)
2026 (1653)
2025 (18109)
2024 (20563)
2023 (22443)
2022 (26927)
2021 (27868)
2020 (23410)
2019 (16258)
2018 (11776)
2017 (13788)
2016 (11885)
2015 (14405)
2014 (10430)
2013 (7528)
2012 (7575)
2011 (7671)
2010 (7465)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18276)
Australia (3110)
California (7075)
Canada (1836)
China (772)
Colorado (248)
Connecticut (252)
Delaware (235)
Europe (39266)
Florida (903)
Georgia (212)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (164)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (737)
Massachusetts (5578)
Michigan (110)
Minnesota (248)
Mississippi (5)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1645)
New Mexico (13)
New York (1760)
North Carolina (826)
North Dakota (6)
Northern California (3473)
Ohio (180)
Oklahoma (11)
Oregon (24)
Pennsylvania (1277)
Puerto Rico (9)
Rhode Island (25)
South America (216)
South Carolina (9)
Southern California (2807)
Tennessee (40)
Texas (905)
United States (23341)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
282,429 Results for "alloy therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines
January 6, 2026
·
4 min read
Press Releases
Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology
January 12, 2026
·
3 min read
Press Releases
Alloy Accelerates Mediar Timeline to the Clinic for Complex Fibrosis Targets
February 3, 2026
·
3 min read
Press Releases
Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers
January 14, 2026
·
4 min read
Press Releases
Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services
October 24, 2025
·
3 min read
Press Releases
Alloy Therapeutics and University of British Columbia Partner to Accelerate Antibody Discovery with Cryo-Electron Microscopy Technology
October 8, 2025
·
3 min read
Press Releases
Alloy Therapeutics Enters Japanese Market by Establishing Operations at Shonan Health Innovation Park
May 22, 2025
·
3 min read
Press Releases
Alloy Therapeutics and Kansai Startup Academia Coalition (KSAC) Announce Strategic Collaboration to Accelerate Global Growth of Japanese Life Science Startups
July 23, 2025
·
4 min read
Business
Alloy Therapeutics Announces Platform License Agreement with Lilly
Alloy Therapeutics announced today a licensing agreement for its murine platforms for fully human antibody discovery with Eli Lilly and Company.
May 21, 2024
·
2 min read
Press Releases
MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs
April 2, 2025
·
4 min read
1 of 28,243
Next
